Error in record details...
ISSN 2278-9723
 

- 
. ; (0):




.

Abstract
No abstract available


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Harini Sivakumar
Articles by Dr. S. Jeganath Dr. S. Jeganath
on Google
on Google Scholar

How to Cite this Article
Pubmed Style

HS, , . Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. IJPRT. 2021; 11(2): 57-66. doi:10.31838/ijprt/11.02.10


Web Style

HS, , . Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. https://www.ijprt.org/?mno=67078 [Access: April 05, 2022]. doi:10.31838/ijprt/11.02.10


AMA (American Medical Association) Style

HS, , . Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. IJPRT. 2021; 11(2): 57-66. doi:10.31838/ijprt/11.02.10



Vancouver/ICMJE Style

HS, , . Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. IJPRT. (2021), [cited April 05, 2022]; 11(2): 57-66. doi:10.31838/ijprt/11.02.10



Harvard Style

, H. S., & (2021) Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. IJPRT, 11 (2), 57-66. doi:10.31838/ijprt/11.02.10



Turabian Style

, Harini Sivakumar, Dr. S. Jeganath Dr. S. Jeganath, and . 2021. Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. International Journal of Pharmacy Research & Technology, 11 (2), 57-66. doi:10.31838/ijprt/11.02.10



Chicago Style

, Harini Sivakumar, Dr. S. Jeganath Dr. S. Jeganath, and . "Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus." International Journal of Pharmacy Research & Technology 11 (2021), 57-66. doi:10.31838/ijprt/11.02.10



MLA (The Modern Language Association) Style

, Harini Sivakumar, Dr. S. Jeganath Dr. S. Jeganath, and . "Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus." International Journal of Pharmacy Research & Technology 11.2 (2021), 57-66. Print. doi:10.31838/ijprt/11.02.10



APA (American Psychological Association) Style

, H. S., & (2021) Effect of Sulfonylurea in Patients with Type 2 Diabetes Mellitus. International Journal of Pharmacy Research & Technology, 11 (2), 57-66. doi:10.31838/ijprt/11.02.10